# RC022 Correctness Repair — Final Code Review

Review fixed point: `3d26a3ab89abb15503614ba4873dfe5cfb7e51ab`

Reviewed staged tree: `e1c94656444c59638f7fe93d62f7ed153eab90c6`

## Verdict

**APPROVED_FOR_PRIVATE_CLOUD_ACCEPTANCE**

- Standards review: `NO_ACTIONABLE_FINDINGS`
- Specification review: `NO_ACTIONABLE_FINDINGS`
- Unresolved P0/P1/P2/P3 findings in the repair diff: none

## Closed review findings

- Replaced the all-locations bypass with one shared supported-city contract for 北京、上海、广州; unsupported, national, regional, and foreign inputs fail before database reads.
- Required explicit mainland evidence for Pfizer and rejected APAC-only or foreign-conflicted descriptors. A Pfizer-specific shared fetch/replay parser accepts audited bare mainland cities without widening JNJ/Gilead boundaries.
- Aligned active First-launch Gate language to 55 and preserved the two-round/no-third-round rule.
- Removed the baseline whitespace defect.
- Pinned cloud actions, Node/container image, runner label, and disabled checkout credential persistence.

## Verification evidence

- Focused Workday/Pfizer regression: 4 files, 184 tests passed.
- Full suite: 174 files, 2,973 tests passed, 3 skipped.
- Prisma Client generation and schema validation: passed.
- TypeScript typecheck and production build: passed.
- `git diff --check`: passed.
- CodeGraph: initialized, synchronized, and up to date; only `.codegraph/.gitignore` is tracked.
- Staged source scan: no high-confidence credential or database artifact match.

## Boundary

This review approves only private-cloud build acceptance of the repaired committed candidate. It does not prove a new crawl qualification, the 55-company launch gate, a production deployment, or a release-state transition.
